Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.

Article  PubMed  Google Scholar 

Scarpa A, Real FX, Luchini C. Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management. Gut. 2018;67:1561–3. https://doi.org/10.1136/gutjnl-2018-316151.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. https://doi.org/10.3322/caac.21442.

Article  PubMed  Google Scholar 

Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008–20. https://doi.org/10.1016/s0140-6736(20)30974-0.

Article  CAS  PubMed  Google Scholar 

Tas F, Sen F, Odabas H, Kılıc L, Keskın S, Yıldız I. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. Int J Clin Oncol. 2013;18:839–46. https://doi.org/10.1007/s10147-012-0474-9.

Article  CAS  PubMed  Google Scholar 

Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007;120:1993–8. https://doi.org/10.1002/ijc.22535.

Article  CAS  PubMed  Google Scholar 

Stolzenberg-Solomon RZ, Graubard BI, Chari S, et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA. 2005;294:2872–8. https://doi.org/10.1001/jama.294.22.2872.

Article  CAS  PubMed  Google Scholar 

Smith RA, Dajani K, Dodd S, et al. Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2008;15:3138–46. https://doi.org/10.1245/s10434-008-0148-z.

Article  PubMed  Google Scholar 

Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10. https://doi.org/10.1056/NEJMoa032295.

Article  CAS  PubMed  Google Scholar 

Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019–26. https://doi.org/10.1001/jama.299.9.1019.

Article  CAS  PubMed  Google Scholar 

Thomas A, Dajani K, Neoptolemos JP, Ghaneh P. Adjuvant therapy in pancreatic cancer. Dig Dis. 2010;28:684–92. https://doi.org/10.1159/000320099.

Article  PubMed  Google Scholar 

Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304:1073–81. https://doi.org/10.1001/jama.2010.1275.

Article  CAS  PubMed  Google Scholar 

Kim YC, Kim HJ, Park JH, et al. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? J Gastroenterol Hepatol. 2009;24:1869–75. https://doi.org/10.1111/j.1440-1746.2009.05935.x.

Article  CAS  PubMed  Google Scholar 

Koom WS, Seong J, Kim YB, Pyun HO, Song SY. CA 19–9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:1148–54. https://doi.org/10.1016/j.ijrobp.2008.06.1483.

Article  CAS  PubMed  Google Scholar 

Stocken DD, Hassan AB, Altman DG, et al. Modelling prognostic factors in advanced pancreatic cancer. Br J Cancer. 2008;99:883–93. https://doi.org/10.1038/sj.bjc.6604568.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550–8. https://doi.org/10.1200/jco.2014.57.9151.

Article  PubMed  Google Scholar 

Kanda M, Tanaka C, Kobayashi D, et al. Preoperative albumin-bilirubin grade predicts recurrences after radical gastrectomy in patients with pT2-4 gastric cancer. World J Surg. 2018;42:773–81. https://doi.org/10.1007/s00268-017-4234-x.

Article  PubMed  Google Scholar 

Lee HG, Lim SB, Lee JL, et al. Preoperative albumin-bilirubin score as a prognostic indicator in patients with stage III colon cancer. Sci Rep. 2022;12:14910. https://doi.org/10.1038/s41598-022-19329-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Xu Q, Zhang H, et al. High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas. Transl Oncol. 2021;14:101038. https://doi.org/10.1016/j.tranon.2021.101038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.

Article  PubMed  PubMed Central  Google Scholar 

Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.

Xu H, Cao D, Zhou D, et al. Baseline albumin-bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis. BMC Cancer. 2023;23:1006. https://doi.org/10.1186/s12885-023-11488-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https://doi.org/10.1186/1745-6215-8-16.

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Zhang X, Wu B, et al. Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation. Pathol Oncol Res. 2023;29:1611175. https://doi.org/10.3389/pore.2023.1611175.

Article  PubMed  PubMed Central  Google Scholar 

Zhang TN, Yin RH, Wang LW. The prognostic and predictive value of the albumin-bilirubin score in advanced pancreatic cancer. Medicine (Baltimore). 2020;99:e20654. https://doi.org/10.1097/md.0000000000020654.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imamura T, Okamura Y, Sugiura T, et al. Clinical significance of preoperative albumin-bilirubin grade in pancreatic cancer. Ann Surg Oncol. 2021;28:6223–35. https://doi.org/10.1245/s10434-021-09593-9.

Article  PubMed  Google Scholar 

Kwon CH, Seo HI, Kim DU, et al. Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer. Korean J Clin Oncol. 2023;19:11–7. https://doi.org/10.14216/kjco.23003.

Article  PubMed  PubMed Central  Google Scholar 

Sakin A, Sahin S, Sakin A, et al. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis. J buon. 2020;25:1941–6.

PubMed  Google Scholar 

Berger JM, Alany A, Berchtold L, et al. Prognosticators of survival in patients with metastatic pancreatic cancer and ascites. ESMO Open. 2023;8:102048. https://doi.org/10.1016/j.esmoop.2023.102048.

Article  CAS  PubMed